Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study
Authors
Keywords
Tumor size assessment, Tumor growth inhibition, Overall survival, Predictive model, Colorectal cancer
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 82, Issue 1, Pages 49-54
Publisher
Springer Nature
Online
2018-04-26
DOI
10.1007/s00280-018-3587-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population Modeling of Tumor Kinetics and Overall Survival to Identify Prognostic and Predictive Biomarkers of Efficacy for Durvalumab in Patients With Urothelial Carcinoma
- (2018) Yanan Zheng et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Lymph node segmentation by dynamic programming and active contours
- (2018) Yongqiang Tan et al. MEDICAL PHYSICS
- Comparative Effects of CT Imaging Measurement on RECIST End Points and Tumor Growth Kinetics Modeling
- (2016) CH Li et al. CTS-Clinical and Translational Science
- Nonlinear Mixed-Effect Models for Prostate-Specific Antigen Kinetics and Link with Survival in the Context of Metastatic Prostate Cancer: a Comparison by Simulation of Two-Stage and Joint Approaches
- (2015) Solène Desmée et al. AAPS Journal
- Progression-Free Survival: Helpful Biomarker or Clinically Meaningless End Point?
- (2015) Alan P. Venook et al. JOURNAL OF CLINICAL ONCOLOGY
- Resampling the N9741 Trial to Compare Tumor Dynamic Versus Conventional End Points in Randomized Phase II Trials
- (2015) Manish R. Sharma et al. JOURNAL OF CLINICAL ONCOLOGY
- Semiautomatic segmentation of liver metastases on volumetric CT images
- (2015) Jiayong Yan et al. MEDICAL PHYSICS
- Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities
- (2015) K Venkatakrishnan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Variability in Assessing Treatment Response: Metastatic Colorectal Cancer as a Paradigm
- (2014) B. Zhao et al. CLINICAL CANCER RESEARCH
- Evaluation of Tumor Size Response Metrics to Predict Survival in Oncology Clinical Trials
- (2014) R Bruno et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial
- (2013) Josep Tabernero et al. EUROPEAN JOURNAL OF CANCER
- Evaluation of Tumor-Size Response Metrics to Predict Overall Survival in Western and Chinese Patients With First-Line Metastatic Colorectal Cancer
- (2013) Laurent Claret et al. JOURNAL OF CLINICAL ONCOLOGY
- Segmentation of lung lesions on CT scans using watershed, active contours, and Markov random field
- (2013) Yongqiang Tan et al. MEDICAL PHYSICS
- Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
- (2012) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions
- (2009) Radojka M. Savic et al. AAPS Journal
- Model-Based Prediction of Phase III Overall Survival in Colorectal Cancer on the Basis of Phase II Tumor Dynamics
- (2009) Laurent Claret et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now